SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Journal of Cardiovascular Pharmacology and Therapeutics
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Kaul, S.
Right arrow Articles by Shah, P. K.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Kaul, S.
Right arrow Articles by Shah, P. K.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Local Delivery of an Ultra-short-acting Nitric Oxide- releasing Compound, DMHD/NO, Is Highly Effective in Inhibiting Acute Platelet-Thrombus Formation on Injured Arterial Strips

Sanjay Kaul, MD

Vascular Physiology and Thrombosis Laboratory of the Atherosclerosis Research Center, the Burns and Allen Research Institute, and the Division of Cardiology, Cedars-Sinai Medical Center, and the UCLA School of Medicine, Los Angeles, California

Tasneem Z. Naqvi, MD, MRCP

Vascular Physiology and Thrombosis Laboratory of the Atherosclerosis Research Center, the Burns and Allen Research Institute, and the Division of Cardiology, Cedars-Sinai Medical Center, and the UCLA School of Medicine, Los Angeles, California

Michael C. Fishbein, MD

Vascular Physiology and Thrombosis Laboratory of the Atherosclerosis Research Center, the Burns and Allen Research Institute, and the Division of Cardiology, Cedars-Sinai Medical Center, and the UCLA School of Medicine, Los Angeles, California

Bojan Cercek, MD, FACC

Vascular Physiology and Thrombosis Laboratory of the Atherosclerosis Research Center, the Burns and Allen Research Institute, and the Division of Cardiology, Cedars-Sinai Medical Center, and the UCLA School of Medicine, Los Angeles, California

Juan J. Badimon, PhD

Mount Sinai Hospital, New York, New York

Thomas C. Hutsell, PhD

Comedicus Incorporated, Minneapolis, Minnesota

Sasha Thomas, BS

Vascular Physiology and Thrombosis Laboratory of the Atherosclerosis Research Center, the Burns and Allen Research Institute, and the Division of Cardiology, Cedars-Sinai Medical Center, and the UCLA School of Medicine, Los Angeles, California

Mia Molloy, BS

Vascular Physiology and Thrombosis Laboratory of the Atherosclerosis Research Center, the Burns and Allen Research Institute, and the Division of Cardiology, Cedars-Sinai Medical Center, and the UCLA School of Medicine, Los Angeles, California

Prediman K. Shah, MD, FACC

Vascular Physiology and Thrombosis Laboratory of the Atherosclerosis Research Center, the Burns and Allen Research Institute, and the Division of Cardiology, Cedars-Sinai Medical Center, and the UCLA School of Medicine, Los Angeles, California

Background: Nitric oxide (NO) plays an important role in modulating platelet-vessel wall interaction following vascular injury. We examined the effects of local infusion of an ultra- short-acting NO-releasing compound: NO adduct of N, N'-dimethylhexanediamine (DMHD/NO), sodium nitroprusside, intravenous nitroglycerin, and aspirin on acute platelet-thrombus formation under conditions of high-shear blood flow in a rabbit extracor poreal perfusion model.

Materials and Methods: Strips of porcine aortic media were perfused in a Badimon cham ber with arterial blood from 20 New Zealand White rabbits for 10 minutes at a shear rate of 1700 s-1. Thrombus formation was quantified by morphometric analysis of thrombus area. Effects on collagen-induced platelet aggregation, blood pressure, bleeding time, and acti vated clotting time were also examined.

Results: DMHD/NO inhibited thrombus area and platelet aggregation in a dose-dependent manner with a 90% reduction in thrombus area (0.018 ± 0.039 vs 0.215 ± 0.085 mm 2/mm control, P < .001) and a 50% reduction in platelet aggregation (4.8 ± 4.4 vs 9.9 ± 4.1 {Omega} con trol, P = .04) at the highest dose of 1.0 nM/kg and 100 µM/L, respectively, without any effects on blood pressure, bleeding time, or activated clotting time. In contrast, equimolar concentrations of sodium nitroprusside and intravenous nitroglycerin had significantly reduced effects on thrombus area compared to DMHD/NO and were associated with signifi cant reductions in blood pressure and prolongation of bleeding time. Aspirin had no effect on thrombus area at 1 µM/kg but reduced thrombus area and prolonged bleeding time at 2 and 5 µM/kg.

Conclusions: Local delivery of DMHD/NO produced a 90% inhibition of experimental acute platelet-thrombosis under high-shear flow conditions without producing adverse systemic hemodynamic or hemostatic effects. Thus, inhibition of thrombus formation by local delivery of a rapidly acting NO donor may be an effective strategy for prevention of arterial injury- induced thrombosis.

Key Words: thrombosis • nitric oxide • diazeniumdiolate • nitroprusside • nitroglycerin • aspirin.

Journal of Cardiovascular Pharmacology and Therapeutics, Vol. 2, No. 3, 181-193 (1997)
DOI: 10.1177/107424849700200305


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




Advertisement